Dietary supplement use is often not reported to health care teams
the ONA take:
Research from Boston Medical Center found that some clinicians are not asking patients about their dietary supplement use, some patients do not disclose their use of them, and dietary supplement use is often not included in medical documentation.
This can challenge the effectiveness of prescription regimens and lead to serious repercussions for patients.
Researchers recently found an amphetamine-like stimulant in dietary supplements. As a result, stores such as the Vitamin Shoppe pulled as many as 25 supplements off their shelves because they contained the ingredient, which was linked to a woman’s stroke.
Another recent study found a number of supplements may even increase the risk of developing certain cancers.
Patients may not know that their health care team needs this information when planning their care or fear being judged for their use of the products.
The researchers conclude that clinicians need to be more conscious of and better educated on the importance of talking with patients of all ages and cultural backgrounds about dietary supplement use.
Some patients do not disclose their use of them, and dietary supplement use is often not included in medical documentation.
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|